Identifying the genomic determinants of aging and longevity in human population studies: Progress and challenges

BioEssays

Volumn 35, Issue 4, 2013, Pages 386-396

  Deelen, Joris ^a   Beekman, Marian ^a   Capri, Miriam ^b   Franceschi, Claudio ^b   Slagboom, P Eline ^a  

^a LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

^b UNIVERSITY OF BOLOGNA   (Italy)

Author keywords

Biomarkers; Genomics; Healthy aging; Human; Longevity

Indexed keywords

APOLIPOPROTEIN E; C REACTIVE PROTEIN; CREATININE; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; HYDROCORTISONE; TRANSCRIPTION FACTOR FKHRL1;

ADL DISABILITY; AGING; ALLELE; ARTICLE; BODY MASS; COPY NUMBER VARIATION; CREATININE BLOOD LEVEL; CROSS-SECTIONAL STUDY; DIASTOLIC BLOOD PRESSURE; DISEASE PREDISPOSITION; DNA DAMAGE; EPIGENETICS; FORCED VITAL CAPACITY; GAIT; GENE LOCUS; GENE SEQUENCE; GENETIC ASSOCIATION; GENETIC LINKAGE; GENETIC SUSCEPTIBILITY; GENOME; GRIP STRENGTH; HOMOZYGOSITY; HUMAN; LIFESPAN; LONGEVITY; METABOLOME; MULTIFACTORIAL INHERITANCE; PHENOTYPE; PROSPECTIVE STUDY; SINGLE NUCLEOTIDE POLYMORPHISM; SYSTOLIC BLOOD PRESSURE; TRANSCRIPTOMICS;

AGING; BIOLOGICAL MARKERS; GENOME, HUMAN; GENOMICS; GENOTYPE; HUMANS; LONGEVITY; PHENOTYPE;

EID: 84874963173     PISSN: 02659247     EISSN: 15211878     Source Type: Journal    
DOI: 10.1002/bies.201200148     Document Type: Article

References (101)

1. Oeppen J, Vaupel JW. 2002. Demography. Broken limits to life expectancy. Science 296: 1029- 31.
2. World Health Organization. 2012. World Health Statistics 2012. Geneva: WHO.
3. Jagger C, Gillies C, Moscone F, Cambois E, et al. 2008. Inequalities in healthy life years in the 25 countries of the European Union in 2005: a cross-national metaregression analysis. Lancet 372: 2124- 31.
4. Christensen K, McGue M, Petersen I, Jeune B, et al. 2008. Exceptional longevity does not result in excessive levels of disability. Proc Natl Acad Sci USA 105: 13274- 9.
5. Terry DF, Sebastiani P, Andersen SL, Perls TT. 2008. Disentangling the roles of disability and morbidity in survival to exceptional old age. Arch Intern Med 168: 277- 83.
6. Atzmon G, Schechter C, Greiner W, Davidson D, et al. 2004. Clinical phenotype of families with longevity. J Am Geriatr Soc 52: 274- 7.
7. Newman AB, Glynn NW, Taylor CA, Sebastiani P, et al. 2011. Health and function of participants in the Long Life Family Study: A comparison with other cohorts. Aging (Albany NY) 3: 63- 76.
8. Terry DF, Wilcox MA, McCormick MA, Pennington JY, et al. 2004. Lower all cause, cardiovascular, and cancer mortality in centenarians' offspring. J Am Geriatr Soc 52: 2074- 6.
9. Westendorp RG, van Heemst D, Rozing MP, Frolich M, et al. 2009. Nonagenarian siblings and their offspring display lower risk of mortality and morbidity than sporadic nonagenarians: the Leiden Longevity Study. J Am Geriatr Soc 57: 1634- 7.
10. Slagboom PE, Beekman M, Passtoors WM, Deelen J, et al. 2011. Genomics of human longevity. Philos Trans R Soc Lond B Biol Sci 366: 35- 42.
11. Sprott RL. 2010. Biomarkers of aging and disease: introduction and definitions. Exp Gerontol 45: 2- 4.
12. Herskind AM, McGue M, Holm NV, Sorensen TI, et al. 1996. The heritability of human longevity: a population-based study of 2872 Danish twin pairs born 1870-1900. Hum Genet 97: 319- 23.
13. Hjelmborg JV, Iachine I, Skytthe A, Vaupel JW, et al. 2006. Genetic influence on human lifespan and longevity. Hum Genet 119: 312- 21.
14. Perls T, Shea-Drinkwater M, Bowen-Flynn J, Ridge SB, et al. 2000. Exceptional familial clustering for extreme longevity in humans. J Am Geriatr Soc 48: 1483- 5.
15. Schoenmaker M, de Craen AJ, de Meijer PH, Beekman M, et al. 2006. Evidence of genetic enrichment for exceptional survival using a family approach: the Leiden Longevity Study. Eur J Hum Genet 14: 79- 84.
16. Gavrilova NS, Gavrilov LA, Evdokushkina GN, Semyonova VG, et al. 1998. Evolution, mutations, and human longevity: European royal and noble families. Hum Biol 70: 799- 804.
17. Finch CE, Tanzi RE. 1997. Genetics of aging. Science 278: 407- 11.
18. Stahl EA, Wegmann D, Trynka G, Gutierrez-Achury J, et al. 2012. Bayesian inference analyses of the polygenic architecture of rheumatoid arthritis. Nat Genet 44: 483- 9.
19. Yang J, Manolio TA, Pasquale LR, Boerwinkle E, et al. 2011. Genome partitioning of genetic variation for complex traits using common SNPs. Nat Genet 43: 519- 25.
20. Hindorff LA, Sethupathy P, Junkins HA, Ramos EM, et al. 2009. Potential etiologic and functional implications of genome-wide association loci for human diseases and traits. Proc Natl Acad Sci USA 106: 9362- 7.
21. Beekman M, Nederstigt C, Suchiman HE, Kremer D, et al. 2010. Genome-wide association study (GWAS)-identified disease risk alleles do not compromise human longevity. Proc Natl Acad Sci USA 107: 18046- 9.
22. Christensen K, Johnson TE, Vaupel JW. 2006. The quest for genetic determinants of human longevity: challenges and insights. Nat Rev Genet 7: 436- 48.
23. de Magalhaes JP, Budovsky A, Lehmann G, Costa J, et al. 2009. The Human Ageing Genomic Resources: online databases and tools for biogerontologists. Aging Cell 8: 65- 72.
24. Fontana L, Partridge L, Longo VD. 2010. Extending healthy life span-from yeast to humans. Science 328: 321- 6.
25. Pettan-Brewer C, Treuting PM. 2011. Practical pathology of aging mice. Pathobiol Aging Age Relat Dis 1: 1.
26. Crimmins EM, Finch CE. 2012. Special issue on genetics of aging. J Gerontol A Biol Sci Med Sci 67: 467- 519.
27. Soerensen M, Dato S, Christensen K, McGue M, et al. 2010. Replication of an association of variation in the FOXO3A gene with human longevity using both case-control and longitudinal data. Aging Cell 9: 1010- 7.
28. Soerensen M, Dato S, Tan Q, Thinggaard M, et al. 2012. Evidence from case-control and longitudinal studies supports associations of genetic variation in APOE, CETP, and IL6 with human longevity. Age (Dordr) in press DOI: 10.1007/s11357-011-9373-7.
29. Zeng Y, Cheng L, Chen H, Cao H, et al. 2010. Effects of FOXO genotypes on longevity: a biodemographic analysis. J Gerontol A Biol Sci Med Sci 65: 1285- 99.
30. Mahley RW, Rall SC Jr. 2000. Apolipoprotein E: far more than a lipid transport protein. Annu Rev Genomics Hum Genet 1: 507- 37.
31. van der Horst A, Burgering BM. 2007. Stressing the role of FoxO proteins in lifespan and disease. Nat Rev Mol Cell Biol 8: 440- 50.
32. Broer L, Demerath EW, Garcia ME, Homuth G, et al. 2012. Association of heat shock proteins with all-cause mortality. Age (Dordr) in press DOI: 10.1007/s11357-012-9417-7.
33. Deelen J, Uh HW, Monajemi R, van Heemst D, et al. 2013. Gene set analysis of GWAS data for human longevity highlights the relevance of the insulin/IGF-1 signaling and telomere maintenance pathways. Age (Dordr) 35: 235- 49.
34. Pawlikowska L, Hu D, Huntsman S, Sung A, et al. 2009. Association of common genetic variation in the insulin/IGF1 signaling pathway with human longevity. Aging Cell 8: 460- 72.
35. Soerensen M, Dato S, Tan Q, Thinggaard M, et al. 2012. Human longevity and variation in GH/IGF-1/insulin signaling, DNA damage signaling and repair and pro/antioxidant pathway genes: cross sectional and longitudinal studies. Exp Gerontol 47: 379- 87.
36. van Heemst D, Beekman M, Mooijaart SP, Heijmans BT, et al. 2005. Reduced insulin/IGF-1 signalling and human longevity. Aging Cell 4: 79- 85.
37. Deelen J, Beekman M, Uh HW, Helmer Q, et al. 2011. Genome-wide association study identifies a single major locus contributing to survival into old age; the APOE locus revisited. Aging Cell 10: 686- 98.
38. Newman AB, Walter S, Lunetta KL, Garcia ME, et al. 2010. A meta-analysis of four genome-wide association studies of survival to age 90 years or older: the Cohorts for Heart and Aging Research in Genomic Epidemiology Consortium. J Gerontol A Biol Sci Med Sci 65: 478- 87.
39. Walter S, Atzmon G, Demerath EW, Garcia ME, et al. 2011. A genome-wide association study of aging. Neurobiol Aging 32: 2109- 28.
40. Sebastiani P, Solovieff N, Dewan AT, Walsh KM, et al. 2012. Genetic signatures of exceptional longevity in humans. PLoS One 7: e29848.
41. Nebel A, Kleindorp R, Caliebe A, Nothnagel M, et al. 2011. A genome-wide association study confirms APOE as the major gene influencing survival in longlived individuals. Mech Ageing Dev 132: 324- 0.
42. Malovini A, Illario M, Iaccarino G, Villa F, et al. 2011. Association study on long-living individuals from Southern Italy identifies rs10491334 in the CAMKIV gene that regulates survival proteins. Rejuvenation Res 14: 283- 91.
43. Kuningas M, Estrada K, Hsu YH, Nandakumar K, et al. 2011. Large common deletions associate with mortality at old age. Hum Mol Genet 20: 4290- 6.
44. Kuningas M, McQuillan R, Wilson JF, Hofman A, et al. 2011. Runs of homozygosity do not influence survival to old age. PLoS One 6: e22580.
45. Beekman M, Blauw GJ, Houwing-Duistermaat JJ, Brandt BW, et al. 2006. Chromosome 4q25, microsomal transfer protein gene, and human longevity: novel data and a meta-analysis of association studies. J Gerontol A Biol Sci Med Sci 61: 355- 62.
46. Boyden SE, Kunkel LM. 2010. High-density genomewide linkage analysis ofexceptional human longevity identifies multiple novel Loci. PLoS One 5: e12432.
47. Puca AA, Daly MJ, Brewster SJ, Matise TC, et al. 2001. A genome-wide scan for linkage to human exceptional longevity identifies a locus on chromosome 4. Proc Natl Acad Sci USA 98: 10505- 8.
48. Reed T, Dick DM, Uniacke SK, Foroud T, et al. 2004. Genome-wide scan for a healthy aging phenotype provides support for a locus near D4S1564 promoting healthy aging. J Gerontol A Biol Sci Med Sci 59: 227- 32.
49. Beekman M, Blanche H, Perola M, Hervonen A, et al. 2013. Genome-wide linkage analysis for human longevity: Genetics of Healthy Ageing Study. Aging Cell in press, DOI: 10.1111/acel.12039.
50. Suh Y, Atzmon G, Cho MO, Hwang D, et al. 2008. Functionally significant insulin-like growth factor I receptor mutations in centenarians. Proc Natl Acad Sci USA 105: 3438- 42.
51. Sebastiani P, Riva A, Montano M, Pham P, et al. 2011. Whole genome sequences of a male and female supercentenarian, ages greater than 114 years. Front Genet 2: 90.
52. Remondini D, Salvioli S, Francesconi M, Pierini M, et al. 2010. Complex patterns of gene expression in human T cells during in vivo aging. Mol Biosyst 6: 1983- 92.
53. de Magalhaes JP, Curado J, Church GM. 2009. Meta-analysis of age-related gene expression profiles identifies common signatures of aging. Bioinformatics 25: 875- 81.
54. Elsharawy A, Keller A, Flachsbart F, Wendschlag A, et al. 2012. Genome-wide miRNA signatures of human longevity. Aging Cell 11: 607- 16.
55. Harries LW, Hernandez D, Henley W, Wood AR, et al. 2011. Human aging is characterized by focused changes in gene expression and deregulation of alternative splicing. Aging Cell 10: 868- 78.
56. Harries LW, Fellows AD, Pilling LC, Hernandez D, et al. 2012. Advancing age is associated with gene expression changes resembling mTOR inhibition: evidence from two human populations. Mech Ageing Dev 133: 556- 62.
57. Hong MG, Myers AJ, Magnusson PK, Prince JA. 2008. Transcriptome-wide assessment of human brain and lymphocyte senescence. PLoS One 3: e3024.
58. Passtoors WM, Beekman M, Gunn D, Boer JM, et al. 2008. Genomic studies in ageing research: the need to integrate genetic and gene expression approaches. J Intern Med 263: 153- 66.
59. Passtoors WM, Boer JM, Goeman JJ, van den Akker EB, et al. 2012. Transcriptional profiling of human familial longevity indicates a role for ASF1A and IL7R. PLoS One 7: e27759.
60. Passtoors WM, Beekman M, Deelen J, van der Breggen R, et al. 2012. Gene expression analysis of mTOR pathway: association with human longevity. Aging Cell in press DOI: 10.1111/acel.12015.
61. Bell JT, Tsai PC, Yang TP, Pidsley R, et al. 2012. Epigenome-wide scans identify differentially methylated regions for age and age-related phenotypes in a healthy ageing population. PLoS Genet 8: e1002629.
62. Hernandez DG, Nalls MA, Gibbs JR, Arepalli S, et al. 2011. Distinct DNA methylation changes highly correlated with chronological age in the human brain. Hum Mol Genet 20: 1164- 72.
63. Rakyan VK, Down TA, Maslau S, Andrew T, et al. 2010. Human agingassociated DNA hypermethylation occurs preferentially at bivalent chromatin domains. Genome Res 20: 434- 9.
64. Garagnani P, Bacalini MG, Pirazzini C, Gori D, et al. 2012. Methylation of ELOVL2 gene as a new epigenetic marker of age. Aging Cell 11: 1132- 4.
65. Martin-Ruiz C, Jagger C, Kingston A, Collerton J, et al. 2011. Assessment of a large panel of candidate biomarkers of ageing in the Newcastle 85+ study. Mech Ageing Dev 132: 496- 502.
66. Newman AB, Sachs MC, Arnold AM, Fried LP, et al. 2009. Total and cause specific mortality in the cardiovascular health study. J Gerontol A Biol Sci Med Sci 64: 1251- 61.
67. Oksuzyan A, Maier H, McGue M, Vaupel JW, et al. 2010. Sex differences in the level and rate of change of physical function and grip strength in the Danish 1905-cohort study. J Aging Health 22: 589- 610.
68. Studenski S, Perera S, Patel K, Rosano C, et al. 2011. Gait speed and survival in older adults. JAMA 305: 50- 8.
69. van Vliet P, Oleksik AM, van Heemst D, de Craen AJ, et al. 2010. Dynamics of traditional metabolic risk factors associate with specific causes of death in old age. J Gerontol A Biol Sci Med Sci 65: 488- 94.
70. Walter S, Mackenbach J, Voko Z, Lhachimi S, et al. 2012. Genetic, physiological, and lifestyle predictors of mortality in the general population. Am J Public Health 102: e3- 10.
71. Barzilai N, Atzmon G, Schechter C, Schaefer EJ, et al. 2003. Unique lipoprotein phenotype and genotype associated with exceptional longevity. JAMA 290: 2030- 40.
72. Ling CH, de Craen AJ, Slagboom PE, Westendorp RG, et al. 2012. Handgrip strength at midlife and familial longevity: the Leiden Longevity Study. Age (Dordr) 34: 1261- 8.
73. Noordam R, Gunn DA, Tomlin CC, Rozing MP, et al. 2012. Cortisol serum levels in familial longevity and perceived age: the Leiden Longevity Study. Psychoneuroendocrinology 37: 1669- 75.
74. Rozing MP, Westendorp RG, de Craen AJ, Frolich M, et al. 2010. Favorable glucose tolerance and lower prevalence of metabolic syndrome in offspring without diabetes mellitus of nonagenarian siblings: the Leiden longevity study. J Am Geriatr Soc 58: 564- 9.
75. Rozing MP, Westendorp RG, de Craen AJ, Frolich M, et al. 2010. Low serum free triiodothyronine levels mark familial longevity: the Leiden Longevity Study. J Gerontol A Biol Sci Med Sci 65: 365- 8.
76. Rozing MP, Mooijaart SP, Beekman M, Wijsman CA, et al. 2011. C-reactive protein and glucose regulation in familial longevity. Age (Dordr) 33: 623- 30.
77. Vaarhorst AA, Beekman M, Suchiman EH, van Heemst D, et al. 2011. Lipid metabolism in long-lived families: the Leiden Longevity Study. Age (Dordr) 33: 219- 27.
78. Wijsman CA, van Heemst D, Rozing MP, Slagboom PE, et al. 2011. Homocysteine and familial longevity: the Leiden Longevity Study. PLoS One 6: e17543.
79. Dall'olio F, Vanhooren V, Chen CC, Slagboom PE, et al. 2012. N-glycomic biomarkers of biological aging and longevity: a link with inflammaging. Ageing Res Rev in press DOI: 10.1016/j.arr.2012.02.002.
80. Yu Z, Zhai G, Singmann P. He Y et al. 2012. Human serum metabolic profiles are age dependent. Aging Cell 11: 960- 7.
81. Ruhaak LR, Uh HW, Beekman M, Koeleman CA, et al. 2010. Decreased levels of bisecting GlcNAc glycoforms of IgG are associated with human longevity. PLoS One 5: e12566.
82. Ruhaak LR, Uh HW, Beekman M, Hokke CH, et al. 2011. Plasma protein Nglycan profiles are associated with calendar age, familial longevity and health. J Proteome Res 10: 1667- 74.
83. Shah SH, Bain JR, Muehlbauer MJ, Stevens RD, et al. 2010. Association of a peripheral blood metabolic profile with coronary artery disease and risk of subsequent cardiovascular events. Circ Cardiovasc Genet 3: 207- 14.
84. Codd V, Nelson CP, Albrecht E, Mangino M, et al. 2013. Identification of seven loci affecting mean telomere length and their association with disease. Nat Genet in press.
85. Huffman JE, Knezevic A, Vitart V, Kattla J, et al. 2011. Polymorphisms in B3GAT1, SLC9A9 and MGAT5 are associated with variation within the human plasma N-glycome of 3533 European adults. Hum Mol Genet 20: 5000- 11.
86. Kettunen J, Tukiainen T, Sarin AP, Ortega-Alonso A, et al. 2012. Genome-wide association study identifies multiple loci influencing human serum metabolite levels. Nat Genet 44: 269- 76.
87. Atzmon G, Cho M, Cawthon RM, Budagov T, et al. 2010. Evolution in health and medicine Sackler colloquium: genetic variation in human telomerase is associated with telomere length in Ashkenazi centenarians. Proc Natl Acad Sci USA 107: 1710- 7.
88. Wijsman CA, van Heemst D, Hoogeveen ES, Slagboom PE, et al. 2013. Ambulant 24-hour glucose rhythms mark calendar and biological age in apparently healthy individuals. Aging Cell in press, DOI: 10.1111/acel.12042.
89. Chen R, Mias GI, Li-Pook-Than J, Jiang L, et al. 2012. Personal omics profiling reveals dynamic molecular and medical phenotypes. Cell 148: 1293- 307.
90. Perls TT, Bochen K, Freeman M, Alpert L, et al. 1999. Validity of reported age and centenarian prevalence in New England. Age Ageing 28: 193- 7.
91. Nebel A, Croucher PJ, Stiegeler R, Nikolaus S, et al. 2005. No association between microsomal triglyceride transfer protein (MTP) haplotype and longevity in humans. Proc Natl Acad Sci USA 102: 7906- 9.
92. Blanche H, Cabanne L, Sahbatou M, Thomas G. 2001. A study of French centenarians: are ACE and APOE associated with longevity? C R Acad Sci III 324: 129- 35.
93. Anselmi CV, Malovini A, Roncarati R, Novelli V, et al. 2009. Association of the FOXO3A locus with extreme longevity in a southern Italian centenarian study. Rejuvenation Res 12: 95- 104.
94. Skytthe A, Valensin S, Jeune B, Cevenini E, et al. 2011. Design, recruitment, logistics, and data management of the GEHA (Genetics of Healthy Ageing) project. Exp Gerontol 46: 934- 45.
95. Bootsma-van der Wiel A, van Exel E, de Craen AJ, Gussekloo J, et al. 2002. A high response is not essential to prevent selection bias: results from the Leiden 85-plus study. J Clin Epidemiol 55: 1119- 25.
96. Weverling-Rijnsburger AW, Blauw GJ, Lagaay AM, Knook DL, et al. 1997. Total cholesterol and risk of mortality in the oldest old. Lancet 350: 1119- 23.
97. Collerton J, Barrass K, Bond J, Eccles M, et al. 2007. The Newcastle 85+ study: biological, clinical and psychosocial factors associated with healthy ageing: study protocol. BMC Geriatr 7: 14.
98. Collerton J, Davies K, Jagger C, Kingston A, et al. 2009. Health and disease in 85 year olds: baseline findings from the Newcastle 85+ cohort study. BMJ 339: b4904.
99. Nybo H, Gaist D, Jeune B, Bathum L, et al. 2001. The Danish 1905 cohort: a genetic-epidemiological nationwide survey. J Aging Health 13: 32- 46.
100. Hofman A, Breteler MM, van Duijn CM, Janssen HL, et al. 2009. The Rotterdam Study: 2010 objectives and design update. Eur J Epidemiol 24: 553- 72.
101. Kannel WB, Feinleib M, McNamara PM, Garrison RJ, et al. 1979. An investigation of coronary heart disease in families. The Framingham offspring study. Am J Epidemiol 110: 281- 90.